Healthcare Sector Stocks
The Healthcare sector has a total of 1065 stocks, with a combined market cap of $8.29 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.21.
Market Cap
8.29T
Revenue
4.59T
Profits
201.1B
PE Ratio
41.21
Profit Margin
4.38%
Dividend Yield
0.43%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 905.79B | 2.61% | 3,486,361 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 554.67B | 2.75% | 7,462,107 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 368.38B | 0.31% | 5,705,670 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 364.31B | 1.20% | 8,453,983 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 288.63B | 1.72% | 1,732,931 | 60.44B |
| 6 | NVS | Novartis AG | 284.82B | 1.07% | 1,271,463 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 280.20B | 0.96% | 8,110,168 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 207.87B | 0.17% | 9,998,741 | 50.57B |
| 9 | AMGN | Amgen Inc. | 181.58B | 0.05% | 2,183,717 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 165.75B | -2.89% | 2,801,577 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 165.19B | -1.40% | 6,666,236 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 153.09B | 0.09% | 1,996,074 | 10.58B |
| 13 | PFE | Pfizer Inc. | 147.96B | 0.35% | 39,419,560 | 63.32B |
| 14 | ABT | Abbott Laboratories | 146.02B | -0.62% | 11,826,739 | 45.13B |
| 15 | CVS | CVS Health Corporation | 125.18B | 3.11% | 12,551,707 | 405.62B |
| 16 | DHR | Danaher Corporation | 117.48B | -0.16% | 6,526,759 | 24.78B |
| 17 | SYK | Stryker Corporation | 115.81B | 2.59% | 3,800,442 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 115.15B | -0.11% | 7,996,965 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 114.99B | 1.06% | 1,194,245 | 12.22B |
| 20 | SNY | Sanofi | 102.20B | -1.03% | 3,147,719 | 54.60B |
| 21 | GSK | GSK plc | 101.78B | 0.18% | 4,114,157 | 43.29B |
| 22 | MDT | Medtronic plc | 97.84B | -0.79% | 10,975,108 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 94.85B | -0.50% | 1,598,103 | 76.39B |
| 24 | MCK | McKesson Corporation | 88.61B | 0.34% | 965,986 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 86.79B | 1.61% | 3,159,995 | 200.42B |
| 26 | CI | The Cigna Group | 79.55B | 0.74% | 2,224,442 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 78.87B | -1.92% | 17,994,229 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 73.24B | -0.49% | 879,328 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 51.96B | 1.34% | 3,806,242 | 28.48B |
| 30 | MDLN | Medline Inc. | 50.85B | 0.42% | 7,703,380 | 29.14B |
| 31 | ARGX | argenx SE | 50.04B | -1.24% | 381,572 | 4.74B |
| 32 | COR | Cencora, Inc. | 49.75B | -2.01% | 2,716,130 | 328.68B |
| 33 | EW | Edwards Lifesciences Corporation | 46.86B | 2.08% | 5,338,748 | 6.30B |
| 34 | CAH | Cardinal Health, Inc. | 43.64B | 2.08% | 2,848,946 | 250.74B |
| 35 | TEVA | Teva Pharmaceutical Industries Limited | 42.21B | 1.23% | 4,458,360 | 17.35B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 41.70B | -0.98% | 600,861 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 39.73B | -2.26% | 3,830,171 | 22.23B |
| 38 | HLN | Haleon plc | 39.59B | -0.88% | 7,932,678 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.92B | -0.19% | 976,700 | 4.29B |
| 40 | HUM | Humana Inc. | 36.60B | 3.22% | 3,077,812 | 137.20B |
| 41 | ONC | BeOne Medicines AG | 35.19B | 0.47% | 181,558 | 5.70B |
| 42 | WAT | Waters Corporation | 32.89B | -4.91% | 1,233,779 | 3.77B |
| 43 | RVMD | Revolution Medicines, Inc. | 31.88B | 2.90% | 1,844,515 | - |
| 44 | A | Agilent Technologies, Inc. | 31.86B | -0.14% | 2,328,893 | 7.07B |
| 45 | ZTS | Zoetis Inc. | 31.17B | -3.38% | 13,089,698 | 9.53B |
| 46 | ALC | Alcon Inc. | 30.92B | -0.53% | 1,496,886 | 10.63B |
| 47 | RPRX | Royalty Pharma plc | 30.66B | 3.00% | 4,153,223 | 2.44B |
| 48 | BIIB | Biogen Inc. | 30.20B | 2.59% | 1,271,858 | 9.94B |
| 49 | RMD | ResMed Inc. | 29.36B | -0.70% | 989,293 | 5.54B |
| 50 | CNC | Centene Corporation | 29.04B | -0.84% | 6,467,832 | 178.33B |
| 51 | IQV | IQVIA Holdings Inc. | 28.77B | -1.53% | 1,515,992 | 16.63B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 28.15B | -0.64% | 4,169,631 | 20.98B |
| 53 | NTRA | Natera, Inc. | 27.97B | -4.35% | 1,664,290 | 2.50B |
| 54 | INSM | Insmed Incorporated | 25.57B | 1.72% | 6,728,248 | 819.56M |
| 55 | VEEV | Veeva Systems Inc. | 25.44B | -2.31% | 2,154,271 | 3.20B |
| 56 | UTHR | United Therapeutics Corporation | 24.60B | -0.38% | 329,510 | 3.17B |
| 57 | PHG | Koninklijke Philips N.V. | 24.37B | -5.11% | 1,820,186 | 20.34B |
| 58 | BNTX | BioNTech SE | 23.32B | -1.53% | 879,891 | 3.23B |
| 59 | DXCM | DexCom, Inc. | 22.60B | -4.20% | 7,032,506 | 4.82B |
| 60 | ILMN | Illumina, Inc. | 21.94B | -0.48% | 2,088,986 | 4.39B |
| 61 | WST | West Pharmaceutical Services, Inc. | 21.36B | -3.10% | 718,366 | 3.22B |
| 62 | DGX | Quest Diagnostics Incorporated | 21.13B | 0.35% | 693,136 | 11.28B |
| 63 | ROIV | Roivant Sciences Ltd. | 20.91B | -0.58% | 5,702,856 | 13.31M |
| 64 | LH | Labcorp Holdings Inc. | 20.86B | -1.14% | 475,785 | 14.14B |
| 65 | MTD | Mettler-Toledo International Inc. | 20.72B | -4.38% | 344,763 | 4.09B |
| 66 | STE | STERIS plc | 20.70B | 0.12% | 979,812 | 5.94B |
| 67 | VTRS | Viatris Inc. | 20.23B | 1.16% | 14,317,091 | 14.56B |
| 68 | MRNA | Moderna, Inc. | 20.01B | -5.35% | 7,508,264 | 2.23B |
| 69 | INCY | Incyte Corporation | 19.74B | -0.31% | 1,630,366 | 5.36B |
| 70 | THC | Tenet Healthcare Corporation | 16.87B | -0.01% | 1,120,288 | 21.46B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 16.22B | 3.54% | 1,565,229 | 3.10B |
| 72 | GMAB | Genmab A/S | 16.20B | -1.99% | 1,975,388 | 3.90B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 16.00B | -0.78% | 2,239,221 | 8.41B |
| 74 | ASND | Ascendis Pharma A/S | 15.13B | 2.50% | 432,458 | 998.25M |
| 75 | SMMT | Summit Therapeutics Inc. | 14.58B | -0.84% | 2,207,467 | - |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.58B | 1.97% | 920,725 | 4.44B |
| 77 | RGC | Regencell Bioscience Holdings Limited | 13.51B | 3.68% | 78,121 | - |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.44B | 4.03% | 3,144,376 | 579.96M |
| 79 | GH | Guardant Health, Inc. | 13.06B | -1.47% | 1,640,070 | 1.08B |
| 80 | EXEL | Exelixis, Inc. | 12.89B | 3.70% | 3,238,614 | 2.38B |
| 81 | SOLV | Solventum Corporation | 12.89B | -0.92% | 2,454,843 | 8.26B |
| 82 | IONS | Ionis Pharmaceuticals, Inc. | 12.82B | 2.33% | 1,360,290 | 1.06B |
| 83 | SNN | Smith & Nephew plc | 12.73B | -0.80% | 1,482,838 | 6.16B |
| 84 | DVA | DaVita Inc. | 12.72B | -1.22% | 638,536 | 13.84B |
| 85 | PEN | Penumbra, Inc. | 12.69B | -0.06% | 273,707 | 1.45B |
| 86 | AXSM | Axsome Therapeutics, Inc. | 12.11B | 5.04% | 815,539 | 708.24M |
| 87 | MEDP | Medpace Holdings, Inc. | 12.10B | 0.96% | 473,996 | 2.68B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.96B | 1.69% | 374,898 | 1.13B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 11.62B | 1.80% | 2,795,229 | 13.65B |
| 90 | COO | The Cooper Companies, Inc. | 11.60B | -0.80% | 2,247,925 | 4.15B |
| 91 | ALGN | Align Technology, Inc. | 11.58B | -2.44% | 636,398 | 4.10B |
| 92 | FMS | Fresenius Medical Care AG | 11.49B | -3.82% | 1,378,514 | 22.32B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.01B | 4.25% | 6,598,462 | 3.58B |
| 94 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.97B | -1.47% | 2,120,789 | 622.01M |
| 95 | ELAN | Elanco Animal Health Incorporated | 10.89B | 1.73% | 8,468,820 | 4.89B |
| 96 | EHC | Encompass Health Corporation | 10.66B | -0.55% | 757,742 | 6.07B |
| 97 | RVTY | Revvity, Inc. | 10.60B | -4.32% | 1,136,011 | 2.90B |
| 98 | UHS | Universal Health Services, Inc. | 10.35B | 0.81% | 933,999 | 17.76B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 10.35B | 1.27% | 2,039,790 | 3.24B |
| 100 | ENSG | The Ensign Group, Inc. | 10.32B | 1.11% | 749,223 | 5.27B |
| 101 | PODD | Insulet Corporation | 10.31B | -6.01% | 1,990,593 | 2.90B |
| 102 | GMED | Globus Medical, Inc. | 10.26B | -0.74% | 1,680,788 | 3.10B |
| 103 | MOH | Molina Healthcare, Inc. | 10.00B | 0.20% | 639,266 | 43.10B |
| 104 | ABVX | ABIVAX Société Anonyme | 9.73B | 0.43% | 730,140 | 5.37M |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.67B | 1.06% | 431,093 | 7.46M |
| 106 | CYTK | Cytokinetics, Incorporated | 9.61B | 3.22% | 2,214,668 | 105.82M |
| 107 | MASI | Masimo Corporation | 9.34B | -0.08% | 752,770 | 1.56B |
| 108 | KRYS | Krystal Biotech, Inc. | 9.21B | 0.73% | 319,859 | 417.30M |
| 109 | ICLR | ICON Public Limited Company | 8.96B | -3.74% | 641,128 | 8.10B |
| 110 | BAX | Baxter International Inc. | 8.94B | -3.24% | 7,899,490 | 11.32B |
| 111 | IBRX | ImmunityBio, Inc. | 8.54B | 0.37% | 10,542,917 | 140.98M |
| 112 | NUVL | Nuvalent, Inc. | 8.31B | 2.62% | 400,986 | - |
| 113 | HALO | Halozyme Therapeutics, Inc. | 8.31B | -1.27% | 2,643,471 | 1.51B |
| 114 | TEM | Tempus AI, Inc. | 8.24B | -2.24% | 5,885,530 | 1.36B |
| 115 | GKOS | Glaukos Corporation | 8.06B | 0.68% | 490,229 | 551.35M |
| 116 | HSIC | Henry Schein, Inc. | 7.91B | 0.14% | 1,284,232 | 13.38B |
| 117 | CRL | Charles River Laboratories International, Inc. | 7.84B | -3.46% | 734,993 | 4.03B |
| 118 | PCVX | Vaxcyte, Inc. | 7.83B | 0.41% | 1,423,838 | - |
| 119 | ATR | AptarGroup, Inc. | 7.52B | -0.14% | 679,532 | 3.87B |
| 120 | OSCR | Oscar Health, Inc. | 7.11B | -0.46% | 11,095,687 | 13.30B |
| 121 | KYMR | Kymera Therapeutics, Inc. | 7.04B | 2.44% | 408,524 | 51.48M |
| 122 | TECH | Bio-Techne Corporation | 7.03B | -5.34% | 3,904,885 | 1.21B |
| 123 | HQY | HealthEquity, Inc. | 6.94B | 2.14% | 1,268,777 | 1.31B |
| 124 | QGEN | Qiagen N.V. | 6.76B | -2.97% | 4,032,489 | 2.10B |
| 125 | PTGX | Protagonist Therapeutics, Inc. | 6.68B | 3.93% | 517,045 | 74.06M |
| 126 | BRKR | Bruker Corporation | 6.68B | -1.97% | 6,131,330 | 3.46B |
| 127 | MIRM | Mirum Pharmaceuticals, Inc. | 6.66B | 2.13% | 6,564,500 | 569.61M |
| 128 | SYRE | Spyre Therapeutics, Inc. | 6.63B | 1.69% | 776,722 | - |
| 129 | PACS | PACS Group, Inc. | 6.54B | 0.71% | 1,814,547 | 5.43B |
| 130 | CGON | CG Oncology, Inc. | 6.53B | 2.68% | 729,263 | 5.07M |
| 131 | BIO | Bio-Rad Laboratories, Inc. | 6.52B | 0.74% | 425,877 | 2.59B |
| 132 | ALKS | Alkermes plc | 6.49B | 1.62% | 3,250,711 | 1.56B |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.42B | 2.64% | 1,128,592 | 217.17M |
| 134 | GRFS | Grifols, S.A. | 6.35B | 1.85% | 777,895 | 8.58B |
| 135 | APGE | Apogee Therapeutics, Inc. | 6.29B | 1.22% | 745,803 | - |
| 136 | LNTH | Lantheus Holdings, Inc. | 6.28B | 0.24% | 1,008,542 | 1.55B |
| 137 | CORT | Corcept Therapeutics Incorporated | 6.13B | 11.57% | 2,307,964 | 769.10M |
| 138 | CNTA | Centessa Pharmaceuticals plc | 6.12B | -0.08% | 1,791,756 | 15.00M |
| 139 | PTCT | PTC Therapeutics, Inc. | 6.09B | -2.08% | 1,240,516 | 827.11M |
| 140 | TGTX | TG Therapeutics, Inc. | 6.04B | 0.26% | 1,828,783 | 700.35M |
| 141 | BLTE | Belite Bio, Inc | 6.04B | -1.30% | 154,459 | - |
| 142 | RGEN | Repligen Corporation | 6.04B | -5.78% | 1,676,490 | 763.34M |
| 143 | CELC | Celcuity Inc. | 6.02B | -0.17% | 989,348 | - |
| 144 | SRRK | Scholar Rock Holding Corporation | 6.01B | 1.99% | 1,690,459 | - |
| 145 | IMVT | Immunovant, Inc. | 5.95B | 2.09% | 1,222,909 | - |
| 146 | COGT | Cogent Biosciences, Inc. | 5.86B | -0.70% | 1,182,248 | - |
| 147 | BLCO | Bausch + Lomb Corporation | 5.79B | 1.37% | 629,178 | 5.21B |
| 148 | TFX | Teleflex Incorporated | 5.76B | 0.78% | 705,688 | 2.13B |
| 149 | CHE | Chemed Corporation | 5.61B | 1.05% | 323,498 | 2.54B |
| 150 | HIMS | Hims & Hers Health, Inc. | 5.59B | -3.56% | 25,957,957 | 2.37B |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.40B | 1.60% | 1,075,293 | 7.50M |
| 152 | AVTR | Avantor, Inc. | 5.37B | -3.67% | 9,127,947 | 6.55B |
| 153 | LEGN | Legend Biotech Corporation | 5.30B | 1.45% | 2,941,515 | 1.14B |
| 154 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | -0.07% | 68,611,410 | 1.11B |
| 155 | LQDA | Liquidia Corporation | 5.12B | 1.75% | 2,271,181 | 288.07M |
| 156 | CRSP | CRISPR Therapeutics AG | 5.09B | -0.15% | 923,019 | 4.10M |
| 157 | STVN | Stevanato Group S.p.A. | 4.88B | -2.08% | 421,404 | 1.39B |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 4.69B | -0.48% | 419,999 | 1.34M |
| 159 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.55B | -0.61% | 379,688 | 754.05M |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 4.43B | -0.36% | 218,576 | 274.48M |
| 161 | SHC | Sotera Health Company | 4.41B | -0.96% | 11,757,499 | 1.19B |
| 162 | MANE | Veradermics, Incorporated | 4.41B | 3.12% | 341,836 | - |
| 163 | NAMS | NewAmsterdam Pharma Company N.V. | 4.34B | -2.93% | 1,749,736 | 22.57M |
| 164 | DOCS | Doximity, Inc. | 4.32B | -11.57% | 12,367,159 | 637.78M |
| 165 | HNGE | Hinge Health, Inc. | 4.18B | -2.10% | 1,591,534 | 646.34M |
| 166 | BLLN | BillionToOne, Inc. | 4.17B | -3.86% | 613,472 | 354.54M |
| 167 | RDNT | RadNet, Inc. | 4.17B | -5.39% | 1,066,204 | 2.14B |
| 168 | CAI | Caris Life Sciences, Inc. | 4.15B | -12.35% | 6,969,894 | 907.29M |
| 169 | TVTX | Travere Therapeutics, Inc. | 4.14B | 3.99% | 2,545,582 | 536.20M |
| 170 | LIVN | LivaNova PLC | 3.98B | 0.96% | 774,148 | 1.43B |
| 171 | AMRX | Amneal Pharmaceuticals, Inc. | 3.95B | -1.67% | 1,458,283 | 3.05B |
| 172 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.95B | 1.54% | 1,174,373 | 18.07M |
| 173 | NVST | Envista Holdings Corporation | 3.89B | -1.48% | 2,538,945 | 2.81B |
| 174 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 0.06% | 2,865,783 | 596.96M |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 3.80B | 2.12% | 1,543,120 | 1.10B |
| 176 | ORKA | Oruka Therapeutics, Inc. | 3.78B | -2.27% | 947,376 | - |
| 177 | ALHC | Alignment Healthcare, Inc. | 3.78B | -0.60% | 31,183,529 | 4.26B |
| 178 | IRTC | iRhythm Holdings, Inc. | 3.77B | -3.09% | 315,557 | 787.85M |
| 179 | MMSI | Merit Medical Systems, Inc. | 3.74B | 2.40% | 1,048,138 | 1.54B |
| 180 | VKTX | Viking Therapeutics, Inc. | 3.68B | 1.21% | 2,275,676 | - |
| 181 | TNGX | Tango Therapeutics, Inc. | 3.68B | 8.55% | 3,301,589 | 56.99M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.63B | -0.74% | 1,130,641 | - |
| 183 | WAY | Waystar Holding Corp. | 3.58B | -3.61% | 2,500,892 | 1.16B |
| 184 | TLX | Telix Pharmaceuticals Limited | 3.58B | 1.25% | 75,831 | 803.79M |
| 185 | OGN | Organon & Co. | 3.50B | 0.23% | 5,805,585 | 6.16B |
| 186 | WRBY | Warby Parker Inc. | 3.50B | 5.71% | 3,330,955 | 890.57M |
| 187 | TWST | Twist Bioscience Corporation | 3.39B | -2.79% | 984,949 | 409.48M |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 3.31B | 1.17% | 992,283 | 2.23B |
| 189 | ERAS | Erasca, Inc. | 3.25B | 0.77% | 4,339,670 | - |
| 190 | BEAM | Beam Therapeutics Inc. | 3.17B | 0.85% | 2,823,637 | 164.01M |
| 191 | ALMS | Alumis Inc. | 3.16B | 5.74% | 841,607 | 24.05M |
| 192 | RCUS | Arcus Biosciences, Inc. | 3.14B | 0.40% | 637,678 | 236.00M |
| 193 | DNLI | Denali Therapeutics Inc. | 3.14B | 1.75% | 1,257,701 | - |
| 194 | LFST | LifeStance Health Group, Inc. | 3.14B | 2.14% | 5,916,415 | 1.49B |
| 195 | MMED | MiniMed Group, Inc. | 3.14B | -5.97% | 1,116,391 | 2.99B |
| 196 | GMRS | GMR Solutions Inc. | 3.12B | -6.80% | 11,388,027 | 5.74B |
| 197 | OPCH | Option Care Health, Inc. | 3.11B | 0.97% | 5,617,636 | 5.67B |
| 198 | BKD | Brookdale Senior Living Inc. | 3.07B | -0.92% | 3,394,380 | 3.00B |
| 199 | VCYT | Veracyte, Inc. | 3.05B | -3.31% | 1,107,287 | 541.74M |
| 200 | ICUI | ICU Medical, Inc. | 3.05B | -0.97% | 312,616 | 2.16B |
| 201 | DYN | Dyne Therapeutics, Inc. | 3.05B | 0.38% | 979,944 | - |
| 202 | NHC | National HealthCare Corporation | 3.04B | 2.77% | 104,461 | 1.53B |
| 203 | ITGR | Integer Holdings Corporation | 3.04B | 5.19% | 1,197,649 | 1.86B |
| 204 | SUPN | Supernus Pharmaceuticals, Inc. | 2.98B | 1.64% | 432,254 | 776.83M |
| 205 | PRVA | Privia Health Group, Inc. | 2.85B | -1.65% | 1,007,566 | 2.25B |
| 206 | VERA | Vera Therapeutics, Inc. | 2.81B | 6.68% | 1,186,037 | - |
| 207 | TARS | Tarsus Pharmaceuticals, Inc. | 2.78B | 8.07% | 1,264,693 | 535.08M |
| 208 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.04% | 1,396,430 | 285.01M |
| 209 | KLRA | Kailera Therapeutics, Inc. | 2.73B | -5.34% | 349,492 | - |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 2.71B | 4.83% | 3,663,265 | 415.62M |
| 211 | GPCR | Structure Therapeutics Inc. | 2.71B | 0.63% | 458,229 | - |
| 212 | HTFL | HeartFlow, Inc. | 2.69B | 6.05% | 927,366 | 176.03M |
| 213 | IRON | Disc Medicine, Inc. | 2.68B | 2.31% | 766,248 | - |
| 214 | TXG | 10x Genomics, Inc. | 2.67B | 0.72% | 2,106,080 | 638.78M |
| 215 | ELVN | Enliven Therapeutics, Inc. | 2.65B | 2.98% | 1,065,949 | - |
| 216 | HAE | Haemonetics Corporation | 2.65B | 5.55% | 1,419,696 | 1.33B |
| 217 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | -1.42% | 1,363,135 | 670.00M |
| 218 | GRAL | GRAIL, Inc. | 2.60B | -2.44% | 502,713 | 156.12M |
| 219 | NKTR | Nektar Therapeutics | 2.56B | -3.16% | 686,844 | 55.63M |
| 220 | CLDX | Celldex Therapeutics, Inc. | 2.55B | 1.59% | 1,157,098 | 865.00K |
| 221 | IDYA | IDEAYA Biosciences, Inc. | 2.54B | 2.77% | 978,275 | 225.27M |
| 222 | RLAY | Relay Therapeutics, Inc. | 2.53B | 2.24% | 2,310,579 | 10.68M |
| 223 | IMNM | Immunome, Inc. | 2.51B | -2.16% | 1,030,477 | 4.02M |
| 224 | NBTX | Nanobiotix S.A. | 2.50B | 7.88% | 54,031 | 38.27M |
| 225 | ACHC | Acadia Healthcare Company, Inc. | 2.50B | 4.34% | 3,269,806 | 3.37B |
| 226 | KOD | Kodiak Sciences Inc. | 2.47B | 0.30% | 401,541 | - |
| 227 | PBH | Prestige Consumer Healthcare Inc. | 2.45B | 2.78% | 750,526 | 1.10B |
| 228 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.44B | 9.09% | 18,948,872 | 885.72M |
| 229 | DFTX | Definium Therapeutics, Inc. | 2.40B | 4.02% | 1,483,684 | - |
| 230 | ZLAB | Zai Lab Limited | 2.30B | 4.81% | 821,176 | 453.28M |
| 231 | GRDN | Guardian Pharmacy Services, Inc. | 2.26B | 2.18% | 379,369 | 1.46B |
| 232 | LMAT | LeMaitre Vascular, Inc. | 2.24B | 0.98% | 321,148 | 256.28M |
| 233 | TMDX | TransMedics Group, Inc. | 2.22B | 0.39% | 2,277,063 | 635.89M |
| 234 | MLYS | Mineralys Therapeutics, Inc. | 2.22B | -8.20% | 1,630,120 | - |
| 235 | ASTH | Astrana Health, Inc. | 2.22B | 1.92% | 606,740 | 3.53B |
| 236 | HCM | HUTCHMED (China) Limited | 2.19B | 0.08% | 28,756 | 548.51M |
| 237 | TRVI | Trevi Therapeutics, Inc. | 2.17B | 3.46% | 2,144,510 | - |
| 238 | PHVS | Pharvaris N.V. | 2.15B | 5.41% | 205,071 | - |
| 239 | TYRA | Tyra Biosciences, Inc. | 2.15B | 3.79% | 644,213 | - |
| 240 | AXGN | Axogen, Inc. | 2.14B | -1.56% | 629,449 | 238.11M |
| 241 | ADPT | Adaptive Biotechnologies Corporation | 2.10B | -3.67% | 1,285,896 | 295.41M |
| 242 | NVCR | NovoCure Limited | 2.10B | -1.15% | 1,153,628 | 674.41M |
| 243 | XRAY | DENTSPLY SIRONA Inc. | 2.09B | -5.09% | 4,407,451 | 3.68B |
| 244 | GENB | Generate Biomedicines, Inc. | 2.07B | 4.71% | 483,614 | 30.30M |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 0.25% | 1,393,665 | 298.30M |
| 246 | SEM | Select Medical Holdings Corporation | 2.04B | 0.12% | 1,654,060 | 5.52B |
| 247 | ESTA | Establishment Labs Holdings Inc. | 2.03B | -0.14% | 427,929 | 229.58M |
| 248 | OCUL | Ocular Therapeutix, Inc. | 2.02B | 0.87% | 2,777,243 | 52.04M |
| 249 | NTLA | Intellia Therapeutics, Inc. | 2.00B | 2.07% | 3,756,578 | 66.09M |
| 250 | SRPT | Sarepta Therapeutics, Inc. | 1.99B | -1.52% | 3,415,231 | 2.18B |
| 251 | BHC | Bausch Health Companies Inc. | 1.98B | -2.22% | 2,102,528 | 10.53B |
| 252 | STOK | Stoke Therapeutics, Inc. | 1.97B | -2.43% | 837,998 | 32.08M |
| 253 | ADMA | ADMA Biologics, Inc. | 1.97B | 1.07% | 4,267,648 | 509.86M |
| 254 | OMCL | Omnicell, Inc. | 1.96B | -1.21% | 740,357 | 1.23B |
| 255 | SION | Sionna Therapeutics, Inc. | 1.95B | 5.32% | 529,640 | - |
| 256 | MD | Pediatrix Medical Group, Inc. | 1.92B | 1.27% | 1,112,558 | 1.93B |
| 257 | TSHA | Taysha Gene Therapies, Inc. | 1.92B | -2.63% | 3,497,521 | 7.47M |
| 258 | AAPG | Ascentage Pharma Group International | 1.92B | 1.04% | 3,605 | 82.08M |
| 259 | MESO | Mesoblast Limited | 1.91B | 2.01% | 159,748 | 65.38M |
| 260 | NEOG | Neogen Corporation | 1.89B | 1.10% | 2,278,597 | 870.56M |
| 261 | CLOV | Clover Health Investments, Corp. | 1.87B | 8.23% | 13,665,849 | 2.21B |
| 262 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 2.96% | 378,585 | 1.20B |
| 263 | OCS | Oculis Holding AG | 1.86B | 3.16% | 696,031 | 1.40M |
| 264 | SGRY | Surgery Partners, Inc. | 1.85B | 2.43% | 2,169,221 | 3.34B |
| 265 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | 2.35% | 1,539,077 | 217.17M |
| 266 | PGNY | Progyny, Inc. | 1.84B | 0.26% | 1,546,109 | 1.29B |
| 267 | QURE | uniQure N.V. | 1.84B | 0.24% | 1,808,034 | 18.09M |
| 268 | ANAB | AnaptysBio, Inc. | 1.82B | -4.41% | 844,562 | 232.39M |
| 269 | RAPP | Rapport Therapeutics, Inc. | 1.82B | 2.26% | 302,459 | 20.00M |
| 270 | SNDA | Sonida Senior Living, Inc. | 1.81B | 4.47% | 674,105 | 367.34M |
| 271 | ZYME | Zymeworks Inc. | 1.79B | 2.80% | 646,783 | 81.26M |
| 272 | MBX | MBX Biosciences, Inc. | 1.78B | 1.41% | 811,852 | - |
| 273 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | 2.26% | 646,879 | 899.11M |
| 274 | VRDN | Viridian Therapeutics, Inc. | 1.76B | 1.07% | 2,218,747 | 70.92M |
| 275 | CAPR | Capricor Therapeutics, Inc. | 1.75B | -3.78% | 1,694,138 | 11.13M |
| 276 | PVLA | Palvella Therapeutics, Inc. | 1.73B | -4.15% | 184,669 | - |
| 277 | ADUS | Addus HomeCare Corporation | 1.73B | -4.04% | 386,689 | 1.45B |
| 278 | INBX | Inhibrx Biosciences, Inc. | 1.72B | 8.56% | 568,851 | 1.30M |
| 279 | ANIP | ANI Pharmaceuticals, Inc. | 1.72B | 1.74% | 308,826 | 923.71M |
| 280 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | 1.23% | 747,367 | 66.05M |
| 281 | INVA | Innoviva, Inc. | 1.71B | 1.76% | 637,226 | 420.69M |
| 282 | UFPT | UFP Technologies, Inc. | 1.70B | -0.62% | 196,851 | 608.85M |
| 283 | VCEL | Vericel Corporation | 1.68B | -0.30% | 730,416 | 292.09M |
| 284 | NRIX | Nurix Therapeutics, Inc. | 1.67B | 1.38% | 979,107 | 71.78M |
| 285 | NUVB | Nuvation Bio Inc. | 1.66B | -1.24% | 5,395,102 | 143.05M |
| 286 | AHG | Akso Health Group | 1.65B | -8.75% | 189,406 | 14.84M |
| 287 | PLSE | Pulse Biosciences, Inc. | 1.63B | 2.83% | 300,830 | 751.00K |
| 288 | IOVA | Iovance Biotherapeutics, Inc. | 1.63B | 2.81% | 7,883,682 | 285.61M |
| 289 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.62B | 0.97% | 1,055,864 | -665.00K |
| 290 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | -3.17% | 13,643,576 | 66.41M |
| 291 | GLUE | Monte Rosa Therapeutics, Inc. | 1.60B | -0.78% | 740,096 | 42.95M |
| 292 | ARDX | Ardelyx, Inc. | 1.58B | -3.48% | 7,236,325 | 427.68M |
| 293 | VIR | Vir Biotechnology, Inc. | 1.57B | -0.74% | 1,215,539 | 65.50M |
| 294 | ALMR | Alamar Biosciences, Inc. | 1.57B | 0.17% | 222,256 | 74.21M |
| 295 | ATAI | AtaiBeckley Inc. | 1.56B | 2.17% | 4,233,363 | 3.49M |
| 296 | NVAX | Novavax, Inc. | 1.52B | -4.05% | 5,174,306 | 596.34M |
| 297 | PRGO | Perrigo Company plc | 1.51B | -1.89% | 2,265,494 | 4.18B |
| 298 | URGN | UroGen Pharma Ltd. | 1.51B | 3.83% | 936,623 | 140.49M |
| 299 | MAZE | Maze Therapeutics, Inc. | 1.49B | 4.58% | 845,321 | 20.00M |
| 300 | ENOV | Enovis Corporation | 1.48B | -1.12% | 1,089,171 | 2.28B |
| 301 | CMPS | COMPASS Pathways plc | 1.48B | 16.97% | 8,644,508 | - |
| 302 | HCSG | Healthcare Services Group, Inc. | 1.48B | -2.89% | 637,740 | 1.85B |
| 303 | AVAH | Aveanna Healthcare Holdings Inc. | 1.47B | -0.73% | 3,636,806 | 2.43B |
| 304 | IMCR | Immunocore Holdings plc | 1.47B | -1.19% | 145,856 | 412.81M |
| 305 | PGEN | Precigen, Inc. | 1.47B | 1.72% | 2,763,366 | 31.60M |
| 306 | PRCT | PROCEPT BioRobotics Corporation | 1.46B | -10.42% | 2,758,616 | 322.02M |
| 307 | DMRA | Damora Therapeutics, Inc. | 1.46B | 4.63% | 392,425 | - |
| 308 | ABCL | AbCellera Biologics Inc. | 1.46B | -3.64% | 5,954,518 | 79.21M |
| 309 | STAA | STAAR Surgical Company | 1.46B | 4.33% | 1,346,407 | 290.38M |
| 310 | IMTX | Immatics N.V. | 1.45B | -5.27% | 1,524,141 | 43.00M |
| 311 | AHCO | AdaptHealth Corp. | 1.44B | -3.91% | 1,863,654 | 3.29B |
| 312 | PAHC | Phibro Animal Health Corporation | 1.43B | -3.61% | 426,330 | 1.50B |
| 313 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | 0.26% | 2,329,659 | 73.62M |
| 314 | ARDT | Ardent Health, Inc. | 1.42B | -1.59% | 420,617 | 6.43B |
| 315 | MPLT | MapLight Therapeutics, Inc. | 1.39B | 1.22% | 190,201 | - |
| 316 | BCAX | Bicara Therapeutics Inc. | 1.38B | -6.21% | 1,364,789 | - |
| 317 | FTRE | Fortrea Holdings Inc. | 1.37B | -0.96% | 958,507 | 2.71B |
| 318 | BHVN | Biohaven Ltd. | 1.36B | -1.85% | 2,417,484 | - |
| 319 | GHRS | GH Research PLC | 1.36B | 1.58% | 112,695 | - |
| 320 | AVBP | ArriVent BioPharma, Inc. | 1.35B | -0.16% | 310,518 | - |
| 321 | ATRC | AtriCure, Inc. | 1.35B | -0.37% | 573,526 | 552.16M |
| 322 | WVE | Wave Life Sciences Ltd. | 1.34B | 2.95% | 7,305,725 | 71.80M |
| 323 | MLTX | MoonLake Immunotherapeutics | 1.34B | 1.21% | 1,188,090 | - |
| 324 | SVRA | Savara Inc. | 1.34B | 3.74% | 1,527,362 | - |
| 325 | CRVS | Corvus Pharmaceuticals, Inc. | 1.33B | -0.81% | 1,372,745 | - |
| 326 | AVLN | Avalyn Pharma Inc. | 1.29B | 3.11% | 402,321 | - |
| 327 | COAG | Hemab Therapeutics Holdings, Inc. | 1.26B | 10.27% | 209,918 | - |
| 328 | ZBIO | Zenas BioPharma, Inc. | 1.26B | 4.02% | 516,448 | 10.00M |
| 329 | KMTS | Kestra Medical Technologies, Ltd. | 1.25B | -0.56% | 290,543 | 83.72M |
| 330 | JBIO | Jade Biosciences, Inc. | 1.24B | -0.63% | 214,752 | - |
| 331 | PNTG | The Pennant Group, Inc. | 1.24B | 0.48% | 430,899 | 1.02B |
| 332 | TDOC | Teladoc Health, Inc. | 1.23B | 0.30% | 3,559,724 | 2.51B |
| 333 | SLS | SELLAS Life Sciences Group, Inc. | 1.21B | 25.10% | 30,684,197 | - |
| 334 | INSP | Inspire Medical Systems, Inc. | 1.21B | -4.86% | 1,142,242 | 915.25M |
| 335 | AGL | agilon health, inc. | 1.20B | 3.55% | 542,669 | 5.82B |
| 336 | AMN | AMN Healthcare Services, Inc. | 1.20B | 4.75% | 1,311,854 | 3.42B |
| 337 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | -2.79% | 1,271,226 | - |
| 338 | DBVT | DBV Technologies S.A. | 1.17B | -2.40% | 196,256 | 5.74M |
| 339 | IVA | Inventiva S.A. | 1.16B | -3.65% | 106,482 | 7.94M |
| 340 | ATEC | Alphatec Holdings, Inc. | 1.16B | -2.45% | 4,239,101 | 787.08M |
| 341 | IART | Integra LifeSciences Holdings Corporation | 1.16B | 8.21% | 1,381,102 | 1.64B |
| 342 | AVNS | Avanos Medical, Inc. | 1.16B | -0.04% | 938,383 | 715.90M |
| 343 | WGS | GeneDx Holdings Corp. | 1.16B | -1.39% | 1,153,965 | 442.68M |
| 344 | ALVO | Alvotech | 1.15B | 3.38% | 528,203 | 562.04M |
| 345 | COLL | Collegium Pharmaceutical, Inc. | 1.13B | -2.30% | 638,465 | 796.33M |
| 346 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.13B | -6.22% | 2,144,289 | 204.73M |
| 347 | EYPT | EyePoint, Inc. | 1.13B | -1.40% | 838,320 | 7.61M |
| 348 | SEPN | Septerna, Inc. | 1.12B | -0.36% | 315,740 | 72.26M |
| 349 | HROW | Harrow, Inc. | 1.11B | 2.74% | 1,737,105 | 268.68M |
| 350 | XERS | Xeris Biopharma Holdings, Inc. | 1.11B | 2.72% | 1,619,436 | 314.85M |
| 351 | NNNN | Anbio Biotechnology | 1.11B | -2.17% | 17,654 | 8.65M |
| 352 | IRMD | IRADIMED CORPORATION | 1.09B | 0.61% | 72,803 | 86.28M |
| 353 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.08B | 1.24% | 3,314,830 | 69.64M |
| 354 | AKTS | Aktis Oncology, Inc. | 1.08B | -1.01% | 129,525 | 8.28M |
| 355 | AORT | Artivion, Inc. | 1.08B | -3.77% | 796,253 | 458.69M |
| 356 | NEO | NeoGenomics, Inc. | 1.08B | -5.60% | 1,467,163 | 745.97M |
| 357 | CNMD | CONMED Corporation | 1.07B | -1.17% | 328,138 | 1.37B |
| 358 | CDNA | CareDx, Inc. | 1.06B | -3.69% | 449,738 | 412.82M |
| 359 | OMER | Omeros Corporation | 1.04B | -2.57% | 2,377,106 | 9.89M |
| 360 | BLFS | BioLife Solutions, Inc. | 1.03B | -0.28% | 321,008 | 101.66M |
| 361 | CRON | Cronos Group Inc. | 1.03B | -1.44% | 1,376,394 | 159.54M |
| 362 | BFLY | Butterfly Network, Inc. | 1.03B | -5.77% | 4,254,092 | 102.92M |
| 363 | CGEM | Cullinan Therapeutics, Inc. | 1.00B | 1.11% | 971,816 | - |
| 364 | INNV | InnovAge Holding Corp. | 1.00B | -2.12% | 324,050 | 949.17M |
| 365 | PHAT | Phathom Pharmaceuticals, Inc. | 997.64M | 0.24% | 1,154,271 | 204.89M |
| 366 | MNKD | MannKind Corporation | 991.73M | -2.13% | 4,510,656 | 360.78M |
| 367 | DSGN | Design Therapeutics, Inc. | 975.58M | -1.08% | 764,118 | - |
| 368 | TNDM | Tandem Diabetes Care, Inc. | 966.95M | -3.95% | 2,640,166 | 1.03B |
| 369 | OMDA | Omada Health, Inc. | 953.55M | 7.58% | 3,172,151 | 283.30M |
| 370 | SDGR | Schrödinger, Inc. | 952.69M | 0.47% | 1,153,217 | 254.91M |
| 371 | EVO | Evotec SE | 944.94M | -9.50% | 141,140 | 859.03M |
| 372 | PHAR | Pharming Group N.V. | 940.29M | -0.92% | 12,619 | 369.49M |
| 373 | LBRX | LB Pharmaceuticals Inc | 926.54M | 3.79% | 179,294 | - |
| 374 | MGTX | MeiraGTx Holdings plc | 922.96M | 1.84% | 365,937 | 81.39M |
| 375 | XNCR | Xencor, Inc. | 917.87M | -0.48% | 761,921 | 97.36M |
| 376 | USPH | U.S. Physical Therapy, Inc. | 915.26M | -1.17% | 350,938 | 787.69M |
| 377 | NUTX | Nutex Health Inc. | 907.65M | -2.64% | 131,038 | 879.95M |
| 378 | PCRX | Pacira BioSciences, Inc. | 906.58M | 0.88% | 407,184 | 734.86M |
| 379 | GERN | Geron Corporation | 904.54M | 0.71% | 25,244,730 | 196.12M |
| 380 | ANNX | Annexon, Inc. | 892.94M | 0.18% | 2,253,381 | - |
| 381 | JANX | Janux Therapeutics, Inc. | 890.98M | 1.39% | 845,508 | 13.73M |
| 382 | SANA | Sana Biotechnology, Inc. | 890.53M | -1.84% | 4,248,286 | - |
| 383 | ORIC | ORIC Pharmaceuticals, Inc. | 890.25M | -2.60% | 1,621,515 | - |
| 384 | INMD | InMode Ltd. | 889.56M | 1.52% | 1,046,712 | 374.64M |
| 385 | GDRX | GoodRx Holdings, Inc. | 883.94M | -2.97% | 1,152,282 | 787.89M |
| 386 | SPTX | Seaport Therapeutics, Inc. | 874.96M | 3.51% | 431,692 | - |
| 387 | BVS | Bioventus Inc. | 868.76M | 2.56% | 379,733 | 576.30M |
| 388 | TALK | Talkspace, Inc. | 867.72M | - | 1,945,837 | 238.37M |
| 389 | VOR | Vor Biopharma Inc. | 862.10M | -3.40% | 692,005 | - |
| 390 | TBPH | Theravance Biopharma, Inc. | 859.39M | 1.15% | 370,681 | 109.78M |
| 391 | ABUS | Arbutus Biopharma Corporation | 851.39M | - | 1,575,792 | 191.45M |
| 392 | BIOA | BioAge Labs, Inc. | 850.83M | 5.22% | 541,690 | 10.32M |
| 393 | DRTS | Alpha Tau Medical Ltd. | 848.41M | -2.43% | 775,489 | - |
| 394 | ODTX | Odyssey Therapeutics, Inc. | 846.30M | 0.22% | 316,311 | 2.98M |
| 395 | ETON | Eton Pharmaceuticals, Inc. | 843.23M | 3.74% | 274,635 | 79.95M |
| 396 | KURA | Kura Oncology, Inc. | 841.58M | -2.07% | 2,427,528 | 71.64M |
| 397 | EVMN | Evommune, Inc. | 838.87M | 2.64% | 356,588 | 10.00M |
| 398 | OPK | OPKO Health, Inc. | 838.15M | 0.91% | 1,729,646 | 581.12M |
| 399 | DRUG | Bright Minds Biosciences Inc. | 830.81M | -0.08% | 147,125 | - |
| 400 | AURA | Aura Biosciences, Inc. | 829.16M | 1.13% | 619,637 | - |
| 401 | ABSI | Absci Corporation | 826.30M | -1.12% | 3,481,428 | 1.84M |
| 402 | CTMX | CytomX Therapeutics, Inc. | 825.09M | -2.32% | 3,019,209 | 35.54M |
| 403 | AMPH | Amphastar Pharmaceuticals, Inc. | 807.78M | 4.69% | 971,188 | 720.53M |
| 404 | ALLO | Allogene Therapeutics, Inc. | 803.91M | 1.30% | 6,459,236 | 22.00K |
| 405 | ESPR | Esperion Therapeutics, Inc. | 803.19M | -0.32% | 12,198,175 | 418.24M |
| 406 | ANRO | Alto Neuroscience, Inc. | 800.95M | -7.23% | 416,747 | - |
| 407 | SSII | SS Innovations International, Inc. | 797.76M | -2.92% | 71,440 | 48.47M |
| 408 | SGP | SpyGlass Pharma, Inc. | 796.22M | -1.33% | 20,327 | - |
| 409 | SPRY | ARS Pharmaceuticals, Inc. | 795.40M | -7.18% | 2,508,057 | 84.28M |
| 410 | RLMD | Relmada Therapeutics, Inc. | 785.61M | 0.54% | 1,043,329 | - |
| 411 | AZTA | Azenta, Inc. | 784.96M | -2.85% | 1,390,973 | 596.48M |
| 412 | LMRI | Lumexa Imaging Holdings, Inc. | 773.45M | -23.33% | 2,579,167 | 1.03B |
| 413 | QDEL | QuidelOrtho Corporation | 753.51M | -0.63% | 2,060,438 | 2.66B |
| 414 | CERT | Certara, Inc. | 745.15M | -5.89% | 5,354,483 | 419.75M |
| 415 | SLDB | Solid Biosciences Inc. | 726.56M | -4.40% | 1,607,966 | - |
| 416 | ACRS | Aclaris Therapeutics, Inc. | 710.89M | 4.30% | 2,245,789 | 8.37M |
| 417 | EHAB | Enhabit, Inc. | 706.40M | - | 4,657,691 | 1.06B |
| 418 | TENX | Tenax Therapeutics, Inc. | 701.24M | -2.14% | 432,732 | - |
| 419 | CBLL | CeriBell, Inc. | 679.55M | 6.93% | 668,592 | 95.07M |
| 420 | PSNL | Personalis, Inc. | 669.17M | 5.79% | 5,780,414 | 64.52M |
| 421 | HSTM | HealthStream, Inc. | 668.74M | -2.01% | 245,522 | 311.78M |
| 422 | EIKN | Eikon Therapeutics, Inc. | 666.45M | 6.76% | 449,730 | - |
| 423 | GYRE | Gyre Therapeutics, Inc. | 665.19M | -0.27% | 35,191 | 117.05M |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 657.36M | 0.63% | 1,019,206 | 122.29M |
| 425 | STRO | Sutro Biopharma, Inc. | 656.09M | -3.20% | 219,625 | 102.48M |
| 426 | AVR | Anteris Technologies Global Corp. | 656.06M | -2.54% | 710,710 | 1.85M |
| 427 | CADL | Candel Therapeutics, Inc. | 655.04M | 2.52% | 1,824,379 | - |
| 428 | KYTX | Kyverna Therapeutics, Inc. | 652.52M | 5.38% | 1,840,123 | - |
| 429 | CBIO | Crescent Biopharma, Inc. | 651.62M | 6.23% | 251,894 | 11.88M |
| 430 | TLRY | Tilray Brands, Inc. | 651.28M | 0.92% | 3,275,299 | 858.28M |
| 431 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 646.67M | -0.62% | 284,702 | - |
| 432 | BWAY | BrainsWay Ltd. | 646.59M | -2.57% | 368,788 | 56.22M |
| 433 | TRAX | First Tracks Biotherapeutics, Inc. | 640.42M | 3.48% | 301,908 | - |
| 434 | ARVN | Arvinas, Inc. | 636.82M | 3.13% | 787,116 | 89.40M |
| 435 | SIBN | SI-BONE, Inc. | 627.99M | 1.87% | 1,544,216 | 206.22M |
| 436 | FBRX | Forte Biosciences, Inc. | 625.41M | 1.52% | 126,467 | - |
| 437 | IRWD | Ironwood Pharmaceuticals, Inc. | 605.78M | -10.02% | 4,412,273 | 361.51M |
| 438 | RIGL | Rigel Pharmaceuticals, Inc. | 594.47M | 9.40% | 918,590 | 299.77M |
| 439 | PRME | Prime Medicine, Inc. | 590.62M | -0.91% | 2,441,631 | 4.03M |
| 440 | CRMD | CorMedix Inc. | 588.32M | -0.13% | 1,127,583 | 311.71M |
| 441 | CABA | Cabaletta Bio, Inc. | 585.35M | -1.10% | 5,869,979 | - |
| 442 | VALN | Valneva SE | 572.49M | -1.67% | 30,663 | 205.07M |
| 443 | DNA | Ginkgo Bioworks Holdings, Inc. | 561.14M | 3.00% | 1,228,636 | 151.40M |
| 444 | PHR | Phreesia, Inc. | 558.41M | -4.37% | 1,142,077 | 480.59M |
| 445 | ANL | Adlai Nortye Ltd. | 557.60M | 6.01% | 42,110 | 5.00M |
| 446 | IMMX | Immix Biopharma, Inc. | 556.10M | -1.59% | 562,071 | - |
| 447 | AGMB | AgomAb Therapeutics NV | 550.59M | -7.45% | 50,373 | - |
| 448 | CSTL | Castle Biosciences, Inc. | 550.49M | -2.58% | 664,486 | 339.92M |
| 449 | FDMT | 4D Molecular Therapeutics, Inc. | 546.29M | 1.06% | 362,759 | 88.24M |
| 450 | CLYM | Climb Bio, Inc. | 545.04M | 2.15% | 375,286 | - |
| 451 | TECX | Tectonic Therapeutic, Inc. | 543.62M | 3.04% | 222,373 | - |
| 452 | NPCE | NeuroPace, Inc. | 539.02M | 0.06% | 434,874 | 99.53M |
| 453 | AVTX | Avalo Therapeutics, Inc. | 530.28M | -0.45% | 1,565,185 | 59.00K |
| 454 | CTNM | Contineum Therapeutics, Inc. | 529.02M | 3.59% | 92,499 | - |
| 455 | PROK | ProKidney Corp. | 528.43M | -1.69% | 631,634 | 893.00K |
| 456 | TCMD | Tactile Systems Technology, Inc. | 525.34M | -1.02% | 401,252 | 343.52M |
| 457 | MDXG | MiMedx Group, Inc. | 524.29M | -0.56% | 1,978,326 | 389.42M |
| 458 | XOMA | XOMA Royalty Corporation | 524.22M | 0.12% | 74,386 | 48.56M |
| 459 | CERS | Cerus Corporation | 520.96M | 1.96% | 2,150,359 | 216.56M |
| 460 | RGNX | REGENXBIO Inc. | 518.24M | -1.95% | 1,809,147 | 170.44M |
| 461 | NGNE | Neurogene Inc. | 515.46M | 3.42% | 135,988 | 925.00K |
| 462 | AQST | Aquestive Therapeutics, Inc. | 513.30M | -0.72% | 2,477,293 | 50.27M |
| 463 | STTK | Shattuck Labs, Inc. | 510.18M | 1.96% | 327,982 | 1.00M |
| 464 | UPB | Upstream Bio, Inc. | 509.37M | 4.58% | 815,600 | 3.32M |
| 465 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 466 | ASMB | Assembly Biosciences, Inc. | 504.11M | 2.92% | 66,459 | 71.10M |
| 467 | PRTA | Prothena Corporation plc | 502.59M | 1.80% | 530,778 | 57.94M |
| 468 | OCGN | Ocugen, Inc. | 497.62M | - | 4,418,524 | 4.47M |
| 469 | OFIX | Orthofix Medical Inc. | 493.55M | 0.25% | 246,111 | 825.37M |
| 470 | OVID | Ovid Therapeutics Inc. | 484.50M | -2.44% | 1,830,890 | 7.12M |
| 471 | FULC | Fulcrum Therapeutics, Inc. | 483.09M | 4.17% | 535,712 | 80.00M |
| 472 | CTKB | Cytek Biosciences, Inc. | 475.24M | -8.91% | 2,021,340 | 204.17M |
| 473 | CTEV | Claritev Corporation | 470.18M | -3.33% | 113,143 | 978.76M |
| 474 | SRTA | Strata Critical Medical, Inc. | 469.84M | -0.73% | 1,144,724 | 228.58M |
| 475 | SGMT | Sagimet Biosciences Inc. | 469.31M | -0.65% | 775,847 | - |
| 476 | EPRX | Eupraxia Pharmaceuticals Inc. | 469.20M | -0.79% | 85,204 | - |
| 477 | PRLD | Prelude Therapeutics Incorporated | 468.69M | 0.43% | 393,097 | 16.72M |
| 478 | EVH | Evolent Health, Inc. | 464.55M | -0.72% | 2,255,638 | 1.89B |
| 479 | KIDS | OrthoPediatrics Corp. | 456.94M | 0.40% | 172,232 | 243.30M |
| 480 | ZURA | Zura Bio Limited | 455.43M | 1.05% | 321,810 | - |
| 481 | AUTL | Autolus Therapeutics plc | 455.11M | 6.87% | 1,996,015 | 75.39M |
| 482 | FLGT | Fulgent Genetics, Inc. | 453.27M | 1.01% | 435,845 | 320.35M |
| 483 | LXEO | Lexeo Therapeutics, Inc. | 452.28M | 1.05% | 1,242,922 | - |
| 484 | ANGO | AngioDynamics, Inc. | 451.83M | -0.55% | 250,644 | 313.73M |
| 485 | KMDA | Kamada Ltd. | 449.94M | -6.88% | 184,377 | 180.46M |
| 486 | LYEL | Lyell Immunopharma, Inc. | 448.92M | -0.05% | 39,433 | 31.00K |
| 487 | ADCT | ADC Therapeutics SA | 442.63M | 1.46% | 1,048,131 | 79.18M |
| 488 | EOLS | Evolus, Inc. | 442.54M | 3.38% | 645,837 | 301.79M |
| 489 | REPL | Replimune Group, Inc. | 437.63M | 29.58% | 17,768,944 | - |
| 490 | CATX | Perspective Therapeutics, Inc. | 435.66M | 1.33% | 974,635 | 618.00K |
| 491 | PRTC | PureTech Health plc | 432.38M | 1.45% | 10,127 | 4.66M |
| 492 | EBS | Emergent BioSolutions Inc. | 429.80M | -2.00% | 574,935 | 676.80M |
| 493 | BBNX | Beta Bionics, Inc. | 429.13M | -1.93% | 757,451 | 110.24M |
| 494 | LRMR | Larimar Therapeutics, Inc. | 425.92M | -0.73% | 822,744 | - |
| 495 | VREX | Varex Imaging Corporation | 424.42M | 2.03% | 553,724 | 857.50M |
| 496 | CCRN | Cross Country Healthcare, Inc. | 424.20M | - | 681,834 | 1.00B |
| 497 | NRC | NRC Health | 420.76M | -2.71% | 78,453 | 138.64M |
| 498 | CGC | Canopy Growth Corporation | 417.01M | - | 4,244,186 | 203.04M |
| 499 | IVVD | Invivyd, Inc. | 415.72M | -1.34% | 1,962,736 | 53.43M |
| 500 | VSTM | Verastem, Inc. | 414.76M | 1.94% | 1,912,420 | 49.59M |